185 related articles for article (PubMed ID: 23197115)
1. Clinical and molecular analysis of six Japanese patients with a renal form of pseudohypoaldosteronism type 1.
Hatta Y; Nakamura A; Hara S; Kamijo T; Iwata J; Hamajima T; Abe M; Okada M; Ushio M; Tsuyuki K; Tajima T
Endocr J; 2013; 60(3):299-304. PubMed ID: 23197115
[TBL] [Abstract][Full Text] [Related]
2. [Mineralocorticoid resistance: pseudohypoaldosteronism type 1].
Fernandes-Rosa FL; Antonini SR
Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):373-81. PubMed ID: 17546235
[TBL] [Abstract][Full Text] [Related]
3. A novel frameshift mutation in NR3C2 leads to decreased expression of mineralocorticoid receptor: a family with renal pseudohypoaldosteronism type 1.
Kawashima Sonoyama Y; Tajima T; Fujimoto M; Hasegawa A; Miyahara N; Nishimura R; Hashida Y; Hayashi A; Hanaki K; Kanzaki S
Endocr J; 2017 Jan; 64(1):83-90. PubMed ID: 27725360
[TBL] [Abstract][Full Text] [Related]
4. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.
Tajima T; Kitagawa H; Yokoya S; Tachibana K; Adachi M; Nakae J; Suwa S; Katoh S; Fujieda K
J Clin Endocrinol Metab; 2000 Dec; 85(12):4690-4. PubMed ID: 11134129
[TBL] [Abstract][Full Text] [Related]
5. A novel nonsense mutation of the mineralocorticoid receptor gene in the renal form of pseudohypoaldosteronism type 1.
Uchida N; Shiohara M; Miyagawa S; Yokota I; Mori T
J Pediatr Endocrinol Metab; 2009 Jan; 22(1):91-5. PubMed ID: 19344080
[TBL] [Abstract][Full Text] [Related]
6. Pseudohypoaldosteronism type 1 due to a novel mutation in the mineralocorticoid receptor gene.
Loomba-Albrecht LA; Nagel M; Bremer AA
Horm Res Paediatr; 2010; 73(6):482-6. PubMed ID: 20453518
[TBL] [Abstract][Full Text] [Related]
7. A case of pseudohypoaldosteronism type 1 with a mutation in the mineralocorticoid receptor gene.
Lee SE; Jung YH; Han KH; Lee HK; Kang HG; Ha IS; Choi Y; Cheong HI
Korean J Pediatr; 2011 Feb; 54(2):90-3. PubMed ID: 21503203
[TBL] [Abstract][Full Text] [Related]
8. Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism.
Sartorato P; Khaldi Y; Lapeyraque AL; Armanini D; Kuhnle U; Salomon R; Caprio M; Viengchareun S; Lombès M; Zennaro MC
Mol Cell Endocrinol; 2004 Mar; 217(1-2):119-25. PubMed ID: 15134810
[TBL] [Abstract][Full Text] [Related]
9. Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1.
Riepe FG; Finkeldei J; de Sanctis L; Einaudi S; Testa A; Karges B; Peter M; Viemann M; Grötzinger J; Sippell WG; Fejes-Toth G; Krone N
J Clin Endocrinol Metab; 2006 Nov; 91(11):4552-61. PubMed ID: 16954160
[TBL] [Abstract][Full Text] [Related]
10. Renin-aldosterone system evaluation over four decades in an extended family with autosomal dominant pseudohypoaldosteronism due to a deletion in the NR3C2 gene.
Hanukoglu A; Vargas-Poussou R; Landau Z; Yosovich K; Hureaux M; Zennaro MC
J Steroid Biochem Mol Biol; 2020 Nov; 204():105755. PubMed ID: 33017655
[TBL] [Abstract][Full Text] [Related]
11. Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.
Pujo L; Fagart J; Gary F; Papadimitriou DT; Claës A; Jeunemaître X; Zennaro MC
Hum Mutat; 2007 Jan; 28(1):33-40. PubMed ID: 16972228
[TBL] [Abstract][Full Text] [Related]
12. Mineralocorticoid receptor mutations and a severe recessive pseudohypoaldosteronism type 1.
Hubert EL; Teissier R; Fernandes-Rosa FL; Fay M; Rafestin-Oblin ME; Jeunemaitre X; Metz C; Escoubet B; Zennaro MC
J Am Soc Nephrol; 2011 Nov; 22(11):1997-2003. PubMed ID: 21903996
[TBL] [Abstract][Full Text] [Related]
13. Two Japanese patients with the renal form of pseudohypoaldosteronism type 1 caused by mutations of NR3C2.
Morikawa S; Komatsu N; Sakata S; Nakamura-Utsunomiya A; Okada S; Tajima T
Clin Pediatr Endocrinol; 2015 Jul; 24(3):135-8. PubMed ID: 26594094
[TBL] [Abstract][Full Text] [Related]
14. Autosomal-dominant pseudohypoaldosteronism type 1 in a Turkish family is associated with a novel nonsense mutation in the human mineralocorticoid receptor gene.
Riepe FG; Krone N; Morlot M; Peter M; Sippell WG; Partsch CJ
J Clin Endocrinol Metab; 2004 May; 89(5):2150-2. PubMed ID: 15126534
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of aldosterone: insight from adult carriers of mineralocorticoid receptor mutations.
Escoubet B; Couffignal C; Laisy JP; Mangin L; Chillon S; Laouénan C; Serfaty JM; Jeunemaitre X; Mentré F; Zennaro MC
Circ Cardiovasc Genet; 2013 Aug; 6(4):381-90. PubMed ID: 23852419
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of the R947X mutation in unrelated families with autosomal dominant pseudohypoaldosteronism type 1: evidence for a mutational hot spot in the mineralocorticoid receptor gene.
Fernandes-Rosa FL; de Castro M; Latronico AC; Sippell WG; Riepe FG; Antonini SR
J Clin Endocrinol Metab; 2006 Sep; 91(9):3671-5. PubMed ID: 16757525
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid resistance.
Zennaro MC; Lombès M
Trends Endocrinol Metab; 2004 Aug; 15(6):264-70. PubMed ID: 15358279
[TBL] [Abstract][Full Text] [Related]
18. Complete clinical resolution of a Japanese family with renal pseudohypoaldosteronism type 1 due to a novel NR3C2 mutation.
Tanaka T; Oki E; Mori T; Tsuruga K; Sohara E; Uchida S; Tanaka H
Nephrology (Carlton); 2019 Apr; 24(4):489-490. PubMed ID: 30919533
[No Abstract] [Full Text] [Related]
19. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I.
Geller DS; Rodriguez-Soriano J; Vallo Boado A; Schifter S; Bayer M; Chang SS; Lifton RP
Nat Genet; 1998 Jul; 19(3):279-81. PubMed ID: 9662404
[TBL] [Abstract][Full Text] [Related]
20. Clinical and molecular features of type 1 pseudohypoaldosteronism.
Riepe FG
Horm Res; 2009; 72(1):1-9. PubMed ID: 19571553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
